Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 7Unknown 2Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 50Pancreatic Neoplasms 14Neoplasms 11Lung Neoplasms 11Neoplasm Metastasis 7Breast Neoplasms 6Brain Neoplasms 6Head and Neck Neoplasms 4Gliosarcoma 4Glioblastoma 4Carcinoma, Hepatocellular 4Squamous Cell Carcinoma of Head and Neck 3Recurrence 3Neuroendocrine Tumors 3Colorectal Neoplasms 3Carcinoma, Squamous Cell 3Prostatic Neoplasms 2Oligodendroglioma 2Non-Squamous Non-Small Cell Lung Cancer 2Glioma 2Familial ependymoma 2Esophageal Neoplasms 2Ependymoma 2Carcinoma, Renal Cell 2Carcinoma 2Carcinoid Tumor 2Astrocytoma 2Urinary Bladder Neoplasms 1Thrombocytosis 1Thoracic Neoplasms 1

Interventions

Fluorouracil 17Cisplatin 17pembrolizumab 12Radiotherapy 11Oxaliplatin 10Irinotecan 9Paclitaxel 6Leucovorin 6Docetaxel 6Carboplatin 6Capecitabine 6Neoadjuvant Therapy 5Trastuzumab 4Panitumumab 4Gefitinib 4Esophagectomy 4Cyclophosphamide 4Cetuximab 4Surgical Procedures, Operative 3Celecoxib 3tegafur-gimeracil-oteracil 2spartalizumab 2sodium glycididazole 2niraparib 2fludarabine 2S 1 (combination) 2Plicamycin 2Pemetrexed 2Lapatinib 2Gemcitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Esophageal Neoplasms × Erlotinib Hydrochloride × Clear all
NCT00539617 2020-03-23

Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery

University of California, San Francisco

Phase 2 Terminated
7 enrolled 9 charts
Gastrointestinal

Esophageal Neoplasms

NCT00442507 2015-07-24

OSI3650

Washington University School of Medicine

Phase 2 Terminated
6 enrolled 7 charts
Gastrointestinal

Esophageal Diseases, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡